Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro

Eli Lilly has announced that its new weight-loss pill is a strong candidate for expedited approval under a recent U.S. program aimed at fast-tracking innovative treatments. This is significant as it could provide a much-needed solution for obesity, a growing health concern in the U.S. The potential quick approval could mean that many individuals struggling with weight management may soon have access to effective medication, highlighting the importance of innovation in healthcare.

Eli Lilly has reported earnings that exceeded expectations by $1.13, along with revenue that topped estimates. This strong financial performance highlights the company's robust growth and effective strategies in the pharmaceutical market, which is crucial for investors and stakeholders looking for stability and potential in their investments.

Eli Lilly has raised its annual revenue guidance, reflecting the strong demand for its weight-loss drug. This increase is significant as it highlights the growing market for obesity treatments and the company's ability to capitalize on this trend. Investors and stakeholders are optimistic about the potential for continued growth, making this a noteworthy development in the pharmaceutical industry.

In the Bronx, long lines have formed at food pantries like the World of Life Christian Fellowship International as around 200 more people than usual seek assistance after SNAP payments were abruptly cut off due to the government shutdown. This situation highlights the growing food insecurity many families face, making it crucial for communities to come together and support those in need during these challenging times.

The pilots union has decided to give Lufthansa some breathing room to address the ongoing pensions dispute, which has successfully averted a potential strike. This development is significant as it allows both parties to negotiate and find a resolution without disrupting air travel, ensuring that passengers can continue to fly without the threat of cancellations or delays.

The ongoing trade war between the U.S. and China has taken a toll on American coal exports, which have plummeted by 14% from January to September this year compared to the same period last year. This decline, highlighted in a recent EIA report, underscores the broader economic impacts of the trade tensions initiated during Trump's presidency. As China halts imports of U.S. coal, it raises concerns about the future of American energy exports and the potential for job losses in the coal industry.

Former President Trump has issued a stark warning to Nigeria, threatening military action in response to escalating violence against Christians, which US conservatives claim amounts to genocide. This situation is critical as it highlights the ongoing religious tensions in Nigeria and raises questions about international intervention and human rights protections.

A small business specializing in women's cycling clothes has taken a stand against Trump's tariffs, joining a lawsuit alongside other small companies like a plumbing supply firm from Utah and a wine importer from New York. This move highlights the struggles small businesses face under these tariffs, emphasizing their resilience and determination to fight for their livelihoods. It matters because it showcases the collective effort of small enterprises to protect their interests and the broader implications of trade policies on local economies.

Penumbra's Q2 2025 earnings call revealed impressive growth, highlighting the company's strong performance in the medical device sector. This growth is significant as it reflects Penumbra's ability to innovate and meet market demands, which could lead to increased investor confidence and potential expansion opportunities.